BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31577267)

  • 21. Clinical characteristics and long-term outcomes in patients with ruptured posterior inferior cerebellar artery aneurysms: a comparative analysis.
    Williamson RW; Wilson DA; Abla AA; McDougall CG; Nakaji P; Albuquerque FC; Spetzler RF
    J Neurosurg; 2015 Aug; 123(2):441-5. PubMed ID: 25884260
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term results of middle cerebral artery aneurysm clipping in the Barrow Ruptured Aneurysm Trial.
    Mooney MA; Simon ED; Brigeman S; Nakaji P; Zabramski JM; Lawton MT; Spetzler RF
    J Neurosurg; 2018 Apr; 130(3):895-901. PubMed ID: 29701554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurological outcomes following intraprocedural rerupture during coil embolization of ruptured intracranial aneurysms.
    Stapleton CJ; Walcott BP; Butler WE; Ogilvy CS
    J Neurosurg; 2015 Jan; 122(1):128-35. PubMed ID: 25361491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients.
    Krischek B; Kasuya H; Onda H; Hori T
    Neurol Med Chir (Tokyo); 2007 Sep; 47(9):389-94; discussion 394-6. PubMed ID: 17895611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery.
    Andaluz N; Zuccarello M
    Neurosurgery; 2004 Nov; 55(5):1050-9. PubMed ID: 15509311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Fenestration of the Lamina Terminalis on Symptomatic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Clinical Research.
    Cengiz SL; Ilik MK; Erdi F; Ustun ME
    Turk Neurosurg; 2016; 26(5):714-9. PubMed ID: 27438619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with short-term outcome.
    Taha MM; Nakahara I; Higashi T; Iwamuro Y; Iwaasa M; Watanabe Y; Tsunetoshi K; Munemitsu T
    Surg Neurol; 2006 Sep; 66(3):277-84; discussion 284. PubMed ID: 16935636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
    Górski R; Zabek M; Jarmuzek P
    Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute angiographic vasospasm and the incidence of delayed cerebral vasospasm: preliminary results.
    Danura H; Schatlo B; Marbacher S; Kerkeni H; Diepers M; Remonda L; Fathi AR; Fandino J
    Acta Neurochir Suppl; 2015; 120():187-90. PubMed ID: 25366622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of low-dose tissue-plasminogen activator intracisternal administration for the prevention of cerebral vasospasm after subarachnoid hemorrhage.
    Yamamoto T; Esaki T; Nakao Y; Mori K
    World Neurosurg; 2010 Jun; 73(6):675-82. PubMed ID: 20934155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term results of surgical treatment of patients with cerebral arterial aneurysms].
    Shetova IM; Shtadler VD; Aronov MS; Piradov MA; Krylov VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(3. Vyp. 2):41-49. PubMed ID: 36950820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    McGirt MJ; Mavropoulos JC; McGirt LY; Alexander MJ; Friedman AH; Laskowitz DT; Lynch JR
    J Neurosurg; 2003 Jun; 98(6):1222-6. PubMed ID: 12816268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A comparative study of the efficacy and safety of the eyebrow supraorbital approach in cerebral aneurysm surgery].
    Alekseev AG; Pichugin AA; Danilov GV; Shayakhmetov NG; Danilov VI
    Zh Vopr Neirokhir Im N N Burdenko; 2019; 83(1):40-52. PubMed ID: 30900687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does treatment modality affect vasospasm distribution in aneurysmal subarachnoid hemorrhage: differential use of intra-arterial interventions for cerebral vasospasm in surgical clipping and endovascular coiling populations.
    Cooke D; Seiler D; Hallam D; Kim L; Jarvik JG; Sekhar L; Ghodke B
    J Neurointerv Surg; 2010 Jun; 2(2):139-44. PubMed ID: 21990594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage.
    Bejjani GK; Bank WO; Olan WJ; Sekhar LN
    Neurosurgery; 1998 May; 42(5):979-86; discussion 986-7. PubMed ID: 9588541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between ruptured aneurysm location, subarachnoid hemorrhage clot thickness, and incidence of radiographic or symptomatic vasospasm in patients enrolled in a prospective randomized controlled trial.
    Abla AA; Wilson DA; Williamson RW; Nakaji P; McDougall CG; Zabramski JM; Albuquerque FC; Spetzler RF
    J Neurosurg; 2014 Feb; 120(2):391-7. PubMed ID: 24313610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study.
    Weidauer S; Lanfermann H; Raabe A; Zanella F; Seifert V; Beck J
    Stroke; 2007 Jun; 38(6):1831-6. PubMed ID: 17446425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage.
    Yahia AM; Kirmani JF; Qureshi AI; Guterman LR; Hopkins LN
    Neurocrit Care; 2005; 3(1):16-23. PubMed ID: 16159090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasospasm probability index: a combination of transcranial doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
    Gonzalez NR; Boscardin WJ; Glenn T; Vinuela F; Martin NA
    J Neurosurg; 2007 Dec; 107(6):1101-12. PubMed ID: 18077946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.
    Vajkoczy P; Meyer B; Weidauer S; Raabe A; Thome C; Ringel F; Breu V; Schmiedek P
    J Neurosurg; 2005 Jul; 103(1):9-17. PubMed ID: 16121967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.